Turn Data into
Genomic Insights

Discover the future of rare disease diagnostics with our AI-driven variant interpretation platform and get answers for your most complex cases at scale.

challenge

Bridging the gap

The development of modern DNA sequencing methods has shifted the bottleneck in genomics away from sequencing.

Today interpretation of variants and identification of disease-causing mutations are the real bottleneck in genomics.

A funnel representing turning data into diagnosis
An image of a mother and a son and an image of a lab employee analyzing DNA

Let genetic testing labs focus on where they matter most

Our platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.

Automated Variant Interpretation

Our AI-driven variant interpretation platform AION automatically identifies likely pathogenic variants in less than 30 minutes.

image of a double helix
A double helix horizontally
BENEFITS

Why AION?

AION allows you to confidently scale your genomic sequencing operations by tackling the interpretation bottleneck

Fast Interpretation

AION provides an interpretation for an exome in less than 30 minutes. Additionally, a comprehensive report, as well as a result export, are generated automatically.

White-box Approach

We believe that every AI prediction needs to be verifiable by a human expert. Hence AION provides insights into the how and why variants were classified and prioritized.

Accurate Decision Support

Our unique AI-based platform provides accurate and reliable decision-support at >93% sensitivity in trios, based on validation studies from 2022-2025.

A screenshot of AION; our AI-driven variant interpretation platform
Product

Introducing AION

AION helps you speed up large parts of your variant interpretation, focus on very complex cases, and grow sustainable business operations.

Denisa Weis, Assoc. Prof., MD, PhD.

Deputy Head of Institute

Institute of Medical Genetics Linz, Austria

„Swift evaluation with excellent success rate. Very practical to use.”

Dr. Andreas Laner

Head of Genomics

MGZ, Germany

“Naturally, the filtering and prioritisation of variants will continue to follow traditional workflows, but I am convinced that in the future we will improve our work with the help of intelligent machine-learning algorithms such as the Nostos AION.”

Thøger Krogh, PhD

Lead Bioinformatician

Amplexa Genetics A/S, Denmark

“The results were amazing, the datasets found exactly what we expected (and then some). Really impressive feat of you and your team."

Get started!

AION requires no implementation and is easy to use.

Want to know more?

Contact us!

Contact us

arrow
Nostos Genomics Logo

Thank you, your submission was received.

blue arrow
back to Homepage
Something went wrong, please try again!
Quo Agency Inc

Want to know more?

Contact us!